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Abstract.  We have previously shown that chicken em- 
bryo fibroblast (CEF) cells and human bladder carci- 
noma (EJ) cells cbntain multiple isoforms of tropo- 
myosin, identified as a, b,  1, 2, and 3  in CEF cells 
and  1, 2,  3, 4,  and 5  in human EJ cells by one-dimen- 
sional SDS-PAGE (Lin, J. J.-C.,  D.  M.  Helfman, S.  H. 
Hughes, and C.-S.  Chou.  1985.  J.  Cell Biol.  100: 
692-703;  and Lin, J.  J.-C., S.  Yamashiro-Matsumura, 
and E  Matsumura.  1984.  Cancer Cells  1:57-65).  Both 
isoform 3  (TM-3) of CEF and isoforms 4,5  (TM-4,-5) 
of human EJ cells are the minor isoforms found re- 
spectively in normal chicken and human cells. They 
have a  lower apparent molecular mass and show a 
weaker affinity to actin filaments when compared to 
the higher molecular mass isoforms.  Using individual 
tropomyosin isoforms immobilized on nitrocellulose 
papers and sequential absorption of polyclonal antise- 
rum on these papers,  we have prepared antibodies 
specific to CEF TM-3  and to CEF TM-1,-2.  In addi- 
tion, two of our antitropomyosin mAbs, CGI36 and 
CG3,  have now been demonstrated by Western blots, 
immunoprecipitation, and two-dimensional gel analysis 
to have specificities to human EJ TM-3 and TM-5, 
respectively. By using these isoform-specific reagents, 
we are able to compare the intracellular localizations 
of the lower and higher molecular mass isoforms in 
both CEF and human EJ cells. We have found that 
both lower and higher molecular mass isoforms of 
tropomyosin are localized along stress fibers of cells, 
as one would expect.  However, the lower molecular 
mass isoforms are also distributed in regions near 
ruffling membranes.  Further evidence for this different 
localization of different tropomyosin isoforms comes 
from double-label immunofluorescence microscopy on 
the same CEF cells with affinity-purified antibody 
against TM-3,  and monoclonal CGfl6 antibody against 
TM-a, -b,  -1, and -2 of CEF tropomyosin. The pres- 
ence of the lower molecular mass isoform of tropo- 
myosin in ruffling membranes may indicate a  novel 
way for the nonmuscle cell to control the stability and 
organization of microfilaments, and to regulate the cell 
motility. 
N 
'ONMUSCLE cells  so far examined express  multiple 
isoforms of tropomyosin (6, 8-11,  13-17, 23-25, 34- 
36, 39, 42, 48, 50, 52).  For example, chicken em- 
bryo  fibroblasts  (CEF) t  contain at  least  five  isoforms of 
tropomyosin (called a, b,  1, 2, and 3) (34, 35), and human 
or rat nonmuscle cells have tropomyosin isoforms 1, 2, 3, 4, 
and 5 (17, 36, 39, 52, 53). CEF isoform 3 (TM-3) and human 
isoforms 4 and 5 (TM-4,-5) have lower apparent molecular 
masses and are the minor isoforms of tropomyosin in normal 
cells. On the contrary, CEF isoforms 1 and 2 (TM-1,-2) and 
human isoforms 1, 2, and 3 (TM-I,-2,-3) are the major iso- 
forms  with  higher  apparent  molecular  masses.  In  trans- 
formed cells, the expression of the minor isoforms increases 
and the amount of at least one of the major isoforms de- 
creases or disappears (7,  19, 20, 30, 31, 34, 36, 41, 45). The 
differential expression of tropomyosin isoforms appears  to 
correlate well with the morphological changes in transformed 
cells. Furthermore, the lower molecular mass isoforms from 
1.  Abbreviations used in this paper:  CEE  chicken  embryo fibroblast. 
CEF and rat nonmuscle cells have been shown to have  a 
weaker actin-binding ability than the higher molecular mass 
isoforms (34, 39).  In this study, we have purified tropomyo- 
sin  isoforms  from  human  bladder  carcinoma  cells  and 
characterized them in terms of actin-binding abilities.  We 
have found that the lower molecular mass isoforms bind actin 
filaments more weakly than the higher molecular mass iso- 
forms.  Together,  these observations  suggest that multiple 
isoforms of tropomyosin may be necessary for nonmuscle 
cells to regulate the organization and function of microfila- 
ments within the cell. However,  the molecular mechanism 
for this regulatory function of tropomyosin isoforms remains 
to be determined. Knowledge concerning the intracellular 
localization and the biochemical properties of individual iso- 
forms may allow us to better evaluate this regulatory function 
of tropomyosin. 
At present, it is not known whether the different isoforms 
have different Iocalizations within the cells.  We have ap- 
proached this question by preparing CEF isoform 3-specific 
and isoforms 1, 2-specific rabbit antibodies by preabsorption 
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CGI36, an mAb that has been shown to recognize only the 
higher molecular mass isoforms of CEF tropomyosin, were 
used to probe the intracellular  localization of tropomyosin 
isoforms in CEF cells. In addition, we have used two mAbs 
prepared previously (CG3 and CGI36) to study the distribu- 
tion of tropomyosin isoforms in human EJ cells.  The CG3 
antibody  recognizes  the  tropomyosin  isoform  5  (TM-5), 
whereas  the  CGI36 reacts  only  to tropomyosin  isoform 3 
(TM-3) of  human bladder carcinoma (EJ) cells. Also, results 
from immunofluorescence studies have suggested that only 
the lower molecular mass isoform (TM-5) of tropomyosin is 
localized in significant amounts near the peripheral runes of 
the cell. 
Materials and Methods 
Cell Culture 
Primary cultures of CEF were prepared from the skins of 10-d-old embryos 
as described previously (35). A human EJ cell line was a generous gift from 
L.  B.  Chen (Danna  Farber Cancer Institute,  Harvard  Medical School). 
Cells were maintained in DME containing 10% FCS and incubated at 37°C 
in a humidified chamber with 5% CO2 and 95%  air. Secondary and ter- 
tiary cultures of CEF cells were used for all experiments. For indirect im- 
munofluorescence, the ceils were grown on 12-mm round glass coverslips 
for 1 or 2 d before use. 
Preparation of Tropomyosin Isoforms  from 
CEF and Human EJ Cells 
Purified tropemyosin was prepared from monolayer cultures of CEF cells 
as described previously (34). This CEF tropomyosin can be resolved into 
five bands, namely, a, b,  1, 2, and 3 isoforms on one-dimensional gels. The 
individual isoforms 1, 2, and 3 were further purified by electroelution of 
the appropriate gel bands on preparative SDS-PAGE and renatured as de- 
scribed previously (33).  These individual isoforms were used for affinity 
purification of isoform-specific antibodies. 
The human EJ tropomyosin isoforms were prepared by the conventional 
methods (19)  including heat treatment, ammonium sulfate fractionation, 
isoelectric point precipitation, and ion-exchange column chromatography. 
Cells were cultured in 150-mm dishes, washed three times with PBS con- 
taining 5 mM MgCI2 and 0.2 mM EGTA, and stored at  -70°C. Cells in 
wet weight of 45 g were suspended in 5 vol of extraction buffer containing 
0.3 M KCI, 50 mM imidazole buffer, pH 7.0, 1 mM EGTA, and 0.5 mM 
MgCI2,  and  homogenized three times for  10  s  each,  using  a  polytron 
homogenizer at the middle setting. The homogenates were further stirred 
for 3 h at 4°C and then centrifuged at 7,000 g for 20 min. The supernatant 
was heated in a boiling water bath for 10 rain and cooled on ice for 30 rain. 
The  denatured  proteins were  removed by  centrifugation at  7,000  g  for 
15 min. The resulting supernatant was fractionated by ammonium sulfate. 
The tropomyosin isoforms were precipitated between 30 and 65 % saturated 
solution. The precipitates were collected by centrifugation at 7,000 g  for 
15  min and dialyzed against  10 mM KH2PO4 buffer,  pH 7.0, containing 
1 M  KCI  and 0.1  mM dithiothreitol (DTT).  The  resulting solution was 
adjusted to pH 4.6 with 1 N HCI to precipitate the EJ tropomyosin, which 
was then collected by centrifugation at 10,000 g for 10 min. The pH 4.6- 
precipitate was dissolved in  10 mM imidazole buffer,  pH 7.0, containing 
30 mM NaCI, 0.1 mM DTT,  and 0.1 mM EGTA, and dialyzed overnight 
against the same buffer.  After centrifugation to remove insoluble material, 
the  sample was  applied  to  a  DEAE-cellulose (DE-52;  Whatman Inc., 
Clifton, NJ) column (1.2  x  10 cm) previously equilibrated with the same 
buffer, and eluted with a  200-ml linear gradient to 380 mM NaCI.  The 
eluted materials containing partially purified tropomyosin were used for 
Western blots. Final purification was performed by chromatography on a 
hydroxyapatite column (Bio-Gel HTP; Bio-Rad Laboratories, Cambridge, 
MA). This column chromatography resolved the human EJ tropomyosin 
isoforms into three fractions, which were isoforms 1, 2, and 3, isoform 3, 
and isoforms 4 and 5. About 0.26, 0.13, and 0.54 mg of tropomyosin TM-I, 
-2,-3, TM-3, and TM-4,-5, respectively, were obtained from 45 g of EJ cells. 
Both TM-1,-2,-3 and TM--4,-5  were used for actin-binding experiments. 
Preparation of  lsoform-specific Antibodies 
Rabbit no. 2 antiserum against chicken gizzard tropomyosin was prepared 
and characterized previously (35, 42). This antiserum reacted strongly with 
isoforms 1 and 2 but weakly with isoform 3 of CEF tropomyosin. Another 
rabbit was immunized with purified CEF tropomyosin by the protocol de- 
scribed previously (42).  The antiserum obtained from this rabbit (desig- 
nated as rabbit no. 6) recognized all isoforms of CEF tropomyosin with a 
stronger reactivity to isoform 3 than to isoforms i  and 2. These two poly- 
clonal antisera were used to prepare isoform-specific antibodies by the se- 
quential  absorption  and  affinity-purification method  as  described  (51). 
Briefly,  ",,10  I.tg of  the  individual  isoforms  were  spotted  on  0.5-cm-' 
nitrocellulose paper, air-dried, and incubated at room temperature for 1 h 
in TBS (Tris buffered saline: 50 mM Tris, pH 7.5,  150 mM NaCI, 0.1% 
NAN3) containing 3 % BSA. Diluted antiserum (rabbit no. 2) was preab- 
sorbed twice with papers containing isoform 3 (1 h each) at room tempera- 
ture. The remaining antiserum was further incubated with papers containing 
isoforms 1 and 2 for 1 h. After a wash in TBS containing 0.5% Tween 20, 
the paper was washed three times with elution buffer (5 rnM glycine HCI, 
pH 2.3, 0.5 M NaCI, 0.5% Tween 20, 100 p,g/ml BSA). These eluates were 
pooled and immediately neutralized by the addition of Na2HPO4 to a final 
concentration of 50 mM.  The pooled eluates were dialyzed against one- 
tenth dilution of TBS overnight and lyophilized. This antibody was desig- 
nated as CEF TM-1,-2-specific antibody (TM-I,-2 Ab). For the preparation 
of isoform 3-specific antibody, the diluted rabbit no. 6 antiserum was preab- 
sorbed twice each with papers containing isoform 1 and isoform 2 of CEF 
tropomyosin to remove antibodies that were common to all isoforms as well 
as specific to isoforms I and 2. The remaining antiserum was incubated with 
papers containing isoform 3 and eluted as described above. This antibody 
was specific to isoform 3 and designated as CEF TM-3-specific antibody 
(TM-3 Ab). 
mAbs CG3 and CG[16 were prepared and characterized as described pre- 
viously (33). The CG3 antibody reacts with all isoforms ofCEF tropomyo- 
sin, whereas the CGI36 antibody recognizes the higher molecular mass iso- 
forms (a, b,  1, and 2) but not the lower molecular mass isoform 3 of CEF 
tropomyosin. However, when characterized on human EJ bladder carci- 
noma tropomyosin by immunoblotting, it was found that CG3 specifically 
reacted with the lower molecular mass isoforms 4 and 5 (EJ TM-4,-5) and 
CGI~6 recognized only isoform 3  (EJ TM-3) of human EJ tropomyosin. 
Two-dimensional gel analyses of the immunoprecipitate from labeled hu- 
man nonmuscle cells by CG3  mAb further demonstrated that CG3 spe- 
cifically reacted with TM-5 isoform. Thus, these antibodies could be used 
as isoform-specific mAbs to examine the intracellular localization of tropo- 
myosin isoforms in human cells. 
Indirect Immunofluorescence Microscopy 
Cells on coverslips were fixed with 3.7% formaldehyde in PBS for 10 rain 
and permeabilized with cold acetone (-10°C) for 5 min. After being rinsed 
with PBS, the coverslips were incubated with various primary antibodies 
in a humidified chamber at 37°C for 30 rain. The coverslips were washed 
extensively with PBS and afterwards reacted with FITCqabeled goat anti- 
mouse IgG or FITC-labeled goat anti-rabbit IgG antibodies. After extensive 
washing in PBS, the coverslips were mounted on slides with gelvatol (32). 
For double-label irnmunofluorescence, the CEF cells on coverslips were 
processed and reacted with a mixture of CG[i6 (the higher molecular mass 
isoform-speciflc antibody) and affinity-purified CEF isoform 3-specific an- 
tibody (TM-3  Ab) as described above.  A  mixture of FITC-labeled goat 
anti-mouse  IgG  (heavy  and  light  chains)  and  tetramethyl  rhodamine 
isothiocyanate-labeled  goat anti-rabbit IgG antibodies was used to detect the 
primary antibodies. The cells were observed and photographed on a Zeiss 
epifluorescence photomicroscope III with a Zeiss 63 x  oil phase 3 lens, as 
described previously (32). 
For the preabsorption experiments, 100 gl of each rabbit antisera were 
mixed with 420 (for no. 2) or 210 ~g (for no. 6) of purified CEF tropomyosin 
isoforms. After incubation at 4°C overnight, the mixtures were centrifuged 
at 12,000 g for 5 min. The resulting supernatants were used for immuno- 
fluorescence microscopy. In the case of preabsorbing mAbs, appropriate 
amounts of EJ tropomyosin (2 ~tg for CG3 and 5 I.tg for CGI36) were mixed 
with 0.4 p.g of purified CG3 or CGI36 antibody and incubated at 4°C for 
30 rain.  The mixture was immediately used for immunofluorescence mi- 
croscopy. 
Other Procedures 
Immunoprecipitation with rabbit no. 2 and no. 6 antibodies was performed 
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instead of formalin-fixed Staphylococcus aureus. A  slight modification of 
this immunoprecipitation was used for lgM mAbs, such as CG3 and CGI~6. 
Briefly, human EJ cells were labeled in vivo with 100 laCi of [35S]methio- 
nine (1052 Ci/mmol) for 16 h in 3 ml of methionine-free media containing 
2.5%  FCS. After washing 3 times with PBS containing 2 mM EGTA and 
5 mM MgCI2,  the cells (100-mm dish) were lysed in I ml of immunopre- 
cipitation buffer (50 mM Tris, pH 8.0, 165 mM NaCI, 0.1 mM EGTA,  1% 
Triton  X-100,  1 mM phenylmethylsulfonyl fluoride [PMSF]) and passed 
through a no. 27 needle at least 10 times. The lysates were clarified by cen- 
trifugation at 110,000 g for 30 rain. To aliquot 300 I.ti  of  the lysates, 5 gl of  mAb 
from ascites fluid was added. After incubation at 4°C for 1 h, 7 ltl of goat 
anti-mouse IgG (heavy and light chains) antibody was added to the mixture; 
this mixture was then incubated for another hour at 4°C. Finally, the im- 
mune complexes were incubated with 100 I.tl of  protein A-Sepharose CL-4B 
for 30 min and then pelleted by microcentrifuge. The pellet was washed 3 
times with the immunoprecipitation buffer and then once with PBS. The an- 
tigen antibodies-protein A-Sepharose complexes were solubilized in 50 t.tl 
of  SDS gel sample buffer and boiled at 100*C for 3 min. Afar centrifugation 
to remove protein A-Sepharose, the supernatant was mixed with purified El 
tropomyosin and analyzed by two-dimensional gel electrophoresis (34). Iso- 
lation of microfilaments from CEF cells was performed according to the 
method described previously with LCKI6 mAb (35). Both the immunopre- 
cipitates and the isolated microfilaments were analyzed on SDS-polyacryl- 
amide gels. SDS-PAGE was carried out according to Laemmli (2, 27) with 
a low concentration of bisacrylamide (12.5 % acrylamide and 0.104 % bis- 
acrylamide). Western immunoblotting was performed as described (33). 
Results 
The specificities of the two rabbit antisera were first exam- 
ined  on  the  total  extract of [35S]methionine-labeled CEF 
cells by immunoprecipitation. As can be seen in Fig. 1, both 
antibodies specifically precipitated five protein bands;  i.e., 
tropomyosin isoforms a, b,  1, 2, and 3, which were identical 
to that found in the isolated microfilament fraction (lane E 
in Fig.  1).  Immunoprecipitation with normal rabbit serum 
gave no specific bands (lane B in Fig. 1). The antibody no. 2 
raised  against  chicken gizzard  tropomyosin cross  reacted 
most strongly with isoforms 1 and 2 and weakly with isoform 
3  in homogenates of CEF cells (lane D  in Fig.  1).  On the 
other hand, the antibody no. 6 raised against CEF tropomyo- 
sin reacted strongly with isoform 3 and weakly with isoform 
1 (lane C in Fig.  1).  Therefore, these two polyclonal anti- 
tropomyosin antibodies (no. 2 and no. 6) were ideally suited 
for the preparation of higher molecular mass (TM-1,-2) and 
lower molecular mass (TM-3) isoform-specific antibodies by 
sequential absorption of common, cross-reactive antibodies 
on purified individual CEF tropomyosin isoforms immobi- 
lized on nitrocellulose papers as detailed under Materials 
and Methods. The specificities of the isoform-specific anti- 
bodies finally obtained were tested by Western immunoblots 
on both partially purified CEF tropomyosin and CEF total 
cell extracts. As can be seen in Fig.  2, the TM-3 isoform- 
specific antibody (TM-3 Ab) reacted only with the TM-3 iso- 
form, whereas TM-1,-2 isoform-specific antibody (TM-1,-2 
Ab) recognized TM-1,-2 isoforms but not TM-3 isoform of 
CEF tropomyosin. 
After staining  for indirect immunofluorescence micros- 
copy, TM-1,-2 antibody revealed stress fiber staining (Fig. 3 
B).  Occasionally, periodic staining could be seen in some 
cells.  However, the ruffling membranes seen by phase mi- 
croscopy were totally negative in  staining  (arrowheads  in 
Fig. 3 B), indicating that the higher molecular mass isoforms 
TM-1,-2 of CEF tropomyosin were not present in this area. 
On the contrary, TM-3 antibody stained both stress fibers 
and ruffling membranes (Fig. 3 D). However, these staining 
Figure L SDS-PAGE  analysis of  the immunoprecipitates of CEF to- 
tal extracts with rabbit anti-tropomyosin antiserum. CEF cells were 
labeled with [35S]methionine  for 20 h in methionine-free medium, 
and processed for immunoprecipitation and microfilament isolation 
as  described  previously (42).  The immunoprecipitates, isolated 
microfilaments, and total cell extracts were analyzed on  12.5% 
SDS-PAGE. After  electrophoresis,  the  gels  were processed  for 
fluorography. (A) Total cell extracts; (B) immunopreeipitate with 
normal rabbit serum; (C) immunoprecipitate with rabbit no. 6 an- 
tiserum  against CEF  tropomyosin; (D)  immunoprecipitate with 
rabbit no. 2 antiserum against chicken gizzard tropomyosin; and 
(E) the isolated microfilament fraction. CEF tropomyosin isoforms 
are indicated as a, b,  1, 2, and 3. 
patterns were not seen in the control experiments with either 
preimmune rabbit serum or antibody preabsorbed with CEF 
tropomyosin (data not shown). Apparently, the lower molec- 
ular mass isoform of  tropomyosin has a significantly different 
distribution within the CEF cell than the higher molecular 
mass isoforms. To further investigate whether different iso- 
forms have different localizations within the same CEF cell, 
we have used double-label indirect immunofluorescence stain- 
ing with rabbit TM-3 antibody and mouse monoclonal CGI36 
antibodies.  The  CGI56  antibody  has  been  shown  to  be 
specific to higher molecular mass isoforms (a, b,  1, and 2) 
of CEF tropomyosin (33). Fig. 4 shows the result from such 
double-label immunofluorescence microscopy. Clearly, the 
lower molecular mass isoform (TM-3) was distributed near 
the ruffling membranes (indicated by arrowheads  in Fig. 4 
C),  in  addition to  stress  fiber localization similar to that 
shown by the higher molecular mass isoforms (a, b,  1, and 
2). Double-label experiments in which the primary antibod- 
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antibodies binding to CEF tropomyosin isoforms. Partially purified 
CEF tropomyosin (lane CEF-TM) and total extract (lane CEF-Total) 
of CEF cells were separated on 12.5% SDS-PAGE. After elec- 
trophoresis, proteins were transferred to nitrocellulose paper and 
either stained with Amido black or reacted with isoform 3-specific 
antibody (TM-3 Ab) or isoforms 1, 2-specific antibody (TM-1,-2 
Ab),  followed by  ~25I-labeled goat  anti-mouse  IgG  (heavy and 
light chains).  Bound antibody was detected by autoradiography. 
Major CEF tropomyosin isoforms are indicated by TM-1, TM-2, 
and TM-3. Note that TM-3 antibody reacted only to the lower mo- 
lecular mass isoform (TM-3),  whereas TM-1,-2 antibody recog- 
nized the higher molecular mass isoforms (TM-1 and TM-2). 
ies were applied in different orders gave essentially the same 
results. This suggested that the absence of fluorescence la- 
beling of the mAb in the ruffling membrane was not due to 
competition or steric hindrance. 
To determine whether this differential localization of tro- 
pomyosin isoforms also exists in other cell lines,  we have 
screened all of our mAbs (33) by immunoblotting on human 
bladder carcinoma El cells to see which antibodies are spe- 
cific to E.I tropomyosin isoforms.  We have found that the 
CG[~6 antibody specifically recognized a higher molecular 
mass isoform (TM-3), whereas the CG3 antibody reacted to 
the lower molecular mass isoforms (TM-4,-5) of EJ tropo- 
myosin (data not shown). As with the lower molecular mass 
tropomyosin isoforms of CEF and rat embryo cells (34, 39), 
human FJ TM-4,-5 also showed a  weaker affinity to actin 
filaments when compared to the higher molecular mass iso- 
form, including TM-3, of EJ tropomyosin (Fig.  5). There- 
fore, it is interesting to determine the intracellular localiza- 
tion  of tropomyosin isoforms TM-3  and  TM-4,-5  within 
human El cells by monoclonal CG3 and CGI36 antibodies. 
To further identify which one of the low molecular mass iso- 
forms of human tropomyosin was recognized by CG3 anti- 
body, two-dimensional gel analysis of the immunoprecipi- 
tates from [35S]methionine-labeled EJ cell extract (Fig. 6 A) 
was carried out. As can be seen in Fig. 6 B, two dimensional 
gel electrophoresis effectively separated the purified EJ tro- 
pomyosin into five spots. The immunoprecipitates obtained 
•  with CG3 antibody showed only TM-5 isoform (Fig. 6 D). 
Consistently,  the  immunoprecipitate with  CG[36  antibody 
contained mainly TM-3 isoform (Fig. 6 C), although in the 
case of heavily loaded gel, TM-2 isoform can also be recog- 
nized.  Therefore, we concluded that  CG3  recognized the 
TM-5 isoform, while CG{~6 reacted mainly with TM-3 iso- 
form of human EJ tropomyosin. 
Immunofluorescence  microscopy was performed with these 
mAbs on human EJ cells. Fig. 7 B shows cells stained with 
CG[~6 antibody to reveal the localization of human tropo- 
myosin 3 (TM-3) isoform. Few stress fibers were stained; ap- 
parently, the majority of El TM-3 isoform was diffusely dis- 
tributed throughout the cytoplasm, except in the peripheral 
ruffle regions (Fig. 7 B). On the other hand, EJ TM-5 iso- 
form recognized by the CG3 antibody obviously is located 
near the ruffling membranes, in addition to stress fibers and 
diffuse dots localization (Fig. 7 D). Both staining patterns by 
CG3 and CG[36 antibodies can be abolished by preabsorp- 
tion of  antibodies with purified EJ tropomyosin (Fig. 7, Fand 
H, respectively). 
Discussion 
In this study, we have demonstrated that within nonmuscle 
cells, the lower molecular mass isoform of tropomyosin dis- 
tributes differently from the higher molecular mass isoforms. 
Although both higher and lower molecular mass  isoform- 
specific antibodies have revealed tropomyosin staining along 
stress fibers (or microfilament bundles), an additional distri- 
bution near the peripheral ruffles can only be observed with 
antibody specific to the lower molecular mass isoform. This 
ruffle location of the lower molecular mass isoform of tropo- 
myosin has been detected not only in CEF cells, but also in 
human bladder carcinoma cells with two different antibody 
probes. Therefore, it is likely that this may be a general pat- 
tern of localization for the lower molecular mass isoform of 
tropomyosin in normal and transformed cells. 
It has been reported previously that tropomyosin could not 
be found in ruffling membranes of cultured cells by immu- 
nofluorescence (28, 29). This failure to detect tropomyosin 
in the ruffle regions might well be due to the use of an anti- 
body that was prepared against skeletal muscle tropomyosin. 
The Journal of Cell Biology,  Volume 107, 1988  566 Figure 3. Indirect immunofluorescence of CEF cells with affinity-purified isoforms 1, 2-specific (A and B) and isoform 3-specific (C and 
D) antibodies. (A and C) Phase-contrast micrographs;  (B and D) fluorescent micrographs.  No peripheral ruffles (indicated by arrowheads 
in B) are stained with isoforrn 1, 2-specific antibody. On the other hand, fluorescence in D is found not only in stress fibers but also periph- 
eral  ruffles. Bar,  10 Ixrn. 
From our experience, an antibody prepared against muscle 
isoforms of tropomyosin tends to react strongly to the higher 
molecular mass isoforms, but only weakly to the lower mo- 
lecular mass isoforms of nonmuscle tropomyosin. This may 
be further supported by the fact that human or rat nonmuscle 
tropomyosin isoform 1 (one of the highest molecular mass 
isoforms) and skeletal muscle tropomyosin isoform are en- 
coded from the same gene by differential splicing mechanism 
(18, 37).  In the present study, we have shown that antibodies 
specific to the higher molecular mass isoforms of nonmuscle 
Lin et al. lntracellular Localization of Nonmuscle Troporayosin lsoforms  567 Figure 4.  Indirect double-label immunofluorescence of CEF cells. Same cells were reacted with both mouse monoclonal CGI36 antibody 
(B) against the higher molecular mass isoforms (i.e., TM-a, -b, -1, and -2) of CEF tropomyosin and affinity-purified rabbit anti-isoform 
3 antibody (C). Fluorescein-conjugated  goat anti-mouse IgG and rhodamine-conjugated  goat anti-rabbit IgG antibodies were used for 
the second antibody in the indirect immunofluorescence. (,4) Phase-contrast micrograph; (B and C) fluorescent micrographs. Monoclonal 
CGI36 antibody stained mainly stress fibers (B), whereas anti-isoform 3 antibody stained peripheral  ruffles as well as stress fibers (C). 
In addition,  more dot staining could be seen with anti-isoform 3 antibody. Bar, 10 pm. 
tropomyosin  do  reveal  the  typical  tropomyosin  location 
along stress fibers, as reported previously (28, 29). Thus, it 
is likely that the peripheral ruffles contain the lower molecu- 
lar mass isoforms of tropomyosin but not the higher molecu- 
lar mass isoforms. 
Localization of nonmuscle tropomyosin in the  ruffle re- 
gion has also been detected by two other investigators (4, 
53).  Boschek  et  al.  (4)  have  reported  that  the  ruffle-like 
flowers,  which appear transiently on the dorsal  surface of 
chicken  embryo cells  undergoing  transformation by  Rous 
sarcoma virus,  contain  tropomyosin and  other  contractile 
proteins such as actin, myosin, and ¢t-actinin. The other re- 
port by Warren et al.  (53)  has demonstrated by antitropo- 
myosin labeling experiments and microinjection studies that 
tropomyosin can occur in peripheral ruffles of normal and 
transformed rat kidney cells.  The antibody that  they have 
used reacts with the higher molecular mass isoforms but not 
with the lower molecular mass isoforms of normal rat kidney 
cells.  Using this antibody, they have observed a redistribu- 
tion  of the  higher  molecular  mass  tropomyosin  isoforms 
from ruffles to stress fibers as these motile normal rat kidney 
cells settle down in contact with one another. However, ruffle 
staining with the same antibody has not been detected in the 
relatively nonmotile normal rat kidney 52E cells, suggesting 
that the higher molecular mass isoforms of tropomyosin are 
not present in the peripheral ruffles of these cells. It should 
be interesting to determine whether or not the lower molecu- 
lar mass tropomyosin isoforms exist in the ruffles of these 
cells. From the present study, we would predict that the lower 
molecular mass isoforms of tropomyosin should be present 
Figure 5. Tests for the actin-binding ability of human EJ tropomyo- 
sin isoforms. Actin (90 pg) and tropomyosin (15 ~tg) were mixed 
in 100 I.tl of a buffer solution of 10 mM Tris, pH 8.0, 30 mM KCI, 
and 10 mM MgCI2. After incubation for 30 min at room tempera- 
ture, the protein samples were centrifuged for 30 min in a Beckman 
airfuge at 26 psi. Aliquots of the resulting supernatants (lanes A and 
C)  and pellets  (lanes B and D) were  analyzed  on  12.5% SDS- 
PAGE. Human EJ tropomyosins are indicated by 1, 2, and 3 and 
4,5. 
The Journal of Cell Biology, Volume 107, 1988  568 Figure 6. Immunoprecipitation analysis. Two-dimensional gel analysis of a total cell extract of human EJ ceils (A) and immunoprecipitated 
proteins by monoclonal CG3 (B and D) or CGI~6 (C) antibodies. Cells were labeled in vivo with [35S]methionine. The immunoprecipita- 
tion was performed as described under Materials and Methods. Purified human EJ tropomyosins were mixed with the labeled cell extract 
and the immunoprecipitates for two-dimensional gel analysis to facilitate the identification of individual tropomyosin isoforms. Two- 
dimensional gels were run with the first dimensional gels containing pH 4-6 ampholytes and the second dimensional slabs comtaining 
12.5% polyacrylamide. Fluorographs (A, C, and D) and Coomassie Blue-stained pattern (B) of the gels are shown with the acidic ends 
to the left. Human noumuscle tropomyosin isoforms TM-1-5 are indicated by numbers 1-5, respectively. A, actin; T, tubulin; HC and LC, 
heavy and light chains, respectively, of mouse IgM and goat IgG (using as secondary antibody) molecules. As can be noted, CG3 preferen- 
tially precipitated TM-5, whereas CGI]6 antibody strongly reacted with TM-3 and weakly with TM-2 isoform. 
in the peripheral ruffles. In this regard, Fowler and Bennett 
(16) have already reported the presence of  tropomyosin in the 
membrane of the human erythrocyte, a nonmotile cell type. 
Based on the similarity in their apparent molecular masses, 
the erythrocyte membrane tropomyosin may in fact be the 
same as the lower molecular mass tropomyosin isoforms of 
nonmuscle cultured cells.  Moreover, all of the erythrocyte 
tropomyosins are thought to associate with the short actin 
filaments in the membrane skeleton (16, 46). Cultured non- 
muscle cells have been shown to contain cortical bundles of 
actin filaments (49), so it is possible that the lower molecular 
mass  isoform  of tropomyosin  detected  in  the  peripheral 
ruffles of these cells may be totally bound to actin filaments. 
At present, the function of tropomyosin in nonmuscle cells 
remains unclear. The multiple isoforms of  tropomyosin shown 
to exist in all nonmuscle cells so far examined may be neces- 
sary for these cells to carry out fine regulation of cell shape 
and cell motility. Although the molecular mechanism for this 
regulation is unknown, several lines of evidence have accu- 
mulated to support the following speculation: cells may per- 
form this regulatory mechanism by controlling the amounts 
of different tropomyosin isoforms expressed.  For example, 
differential expression of tropomyosin isoforms has been ob- 
served in transformed cells, and these changes in tropomyo- 
sin isoforms may be responsible for rearrangement of micro- 
filament bundles and/or changes in cell shape (7, 19, 20, 30, 
Lin et al. lntracellular Localization of Nonmuscle Tropomyosin Isoforms  569 Figure  7.  Indirect  immunoffuo- 
rescence of human EJ cells  with 
monoclonal CC,-1~6  antibody aooainst 
TM-3 isoform (A and B), mono- 
clonal CG3 antibody against TM- 
5 isoform (C and D), and preab- 
sorbed  antibodies  (E and  F  for 
CGI~6, and  G and  H  for CG3). 
(A, C, E, and G) Phase-contrast 
micrographs;  (B,  D,  F,  and  H) 
fluorescent  micrographs.  The 
diffuse,  dot stain  throughout the 
cytoplasm,  except  the  ruffle  re- 
gions, was the major staining pat- 
tern  with  CGI~6 antibody  (B). 
Occasionally,  few  stress  fiber 
staining  was  also observed.  On 
the  other  hand,  not  only  stress 
fiber and diffuse  stains,  but also 
ruffle stain were readily detected 
by CG3  antibody  (D).  Fluores- 
cent micrographs (F and H) ob- 
tained from preabsorption experi- 
ments  were taken  and printed  at 
the same exposure time as that for 
those  shown  in  B  and  D.  Bar, 
10 p.m. 
31, 34, 36, 41, 45). Alternatively, cells may distribute specific 
isoforms in a localized area to affect the performance of par- 
ticular microfilament functions.  For example,  we have now 
shown that the lower molecular mass tropomyosin isoforms 
with weaker actin-binding ability are localized more abun- 
dantly in highly motile regions (ruffles) than the higher mo- 
lecular mass isoforms of tropomyosin. Another possibility is 
that the multiple  isoforms of nonmuscle tropomyosin may 
play a role in modulating the organization of microfilaments 
in cells by regulating the interaction between actin and other 
The Journal of Cell Biology, Volume 107, 1988  570 actin-binding  proteins.  For example,  skeletal  muscle  and 
nonmuscle  tropomyosins  have  been  shown  to  inhibit  the 
binding of filamin, spectrin, a-actinin, caldesmon,  and 55- 
kD protein to actin filaments (12, 26, 38, 40, 44, 47, 54), as 
well as the action of fragmin, villin, gelsolin, DNase I, actin- 
depolymerizing protein (destrin), and actin-depolymerizing 
factor on actin filaments (1, 3, 5,  13, 21, 22, 43). Obviously, 
the differential distribution of tropomyosin isoforms within 
the nonmuscle cell could be very  critical  to this  sort of a 
modulating  function. 
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